reports
Pharming Group reports third quarter 2025 financial results with signi...
Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth in patients and prescribersJoenja® (leniolisib) third quarter revenue increased by 35% to US$15.1 million, compared to third quarter 2024, reflecting strong growth in patients on therapy FDA granted priority review of sNDA for leniolisib for c...
WINFARM : Revenue growth of +5.1% to 30 September 2025.
WINFARM : Revenue growth of +5.1% to 30 September 2025. PRESS RELEASE Loudéac, 5 November 2025 Revenue growth of +5.1% to 30 September 2025 WINFARM (ISIN: FR0014000P11 - ticker: ALWF), the leading French player in distance-selling of products and solutions for the agricultural and livestock industry, is today reporting its revenue for the third quarter of 2025 and for the first nine months of 2025. in €m, unauditedQ3 2024Q3 2025Chg. 9M 20249M 2025Chg.Farming Supplies30.131.2+3.8% 92.896.4+3.9%Farming Production4.33.9-9.9% 10.612.1+13.9%Other10.70.9+27.7% 1.72.1+17.2%TOTAL35.136.0+2.6%...
WINFARM : Croissance de +5,1% du chiffre d’affaires au 30 septembre 20...
WINFARM : Croissance de +5,1% du chiffre d’affaires au 30 septembre 2025. COMMUNIQUE DE PRESSE Loudéac, 5 novembre 2025 Croissance de +5,1% du chiffre d’affaires au 30 septembre 2025 WINFARM (ISIN : FR0014000P11 – mnémonique : ALWF), n°1 français de la vente à distance pour le monde agricole, annonce ce jour la publication du chiffre d’affaires du troisième trimestre 2025 et en cumul sur les neuf premiers mois de l’exercice 2025. En M€, non auditéT3 2024T3 2025VAR 9 mois 20249 mois 2025VARAgroFourniture30,131,2+3,8% 92,896,4+3,9%AgroProduction4,33,9-9,9% 10,612,1+13,9%Autres10,70,9+27...
- Juan Ros-Padilla
- Thomas Zlowodzki
SSAB A SSAB AB CLASS A
BEN BENETEAU SA
ALDEL DELFINGEN INDUSTRY SA
WHA WERELDHAVE N.V.
OERL OC OERLIKON CORPORATION AG
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
NOEJ NORMA GROUP SE
NEX NEXANS SA
COR CORTICEIRA AMORIM SGPS SA
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BCHN BURCKHARDT COMPRESSION HOLDING AG
B7E BLUE CAP
COFA COFACE SA
ATRY ATRYS HEALTH
SFQ SAF-HOLLAND SE
ADTN ADTRAN HOLDINGS INC
- Juan Ros-Padilla
- Thomas Zlowodzki
SSAB A SSAB AB CLASS A
BEN BENETEAU SA
ALDEL DELFINGEN INDUSTRY SA
WHA WERELDHAVE N.V.
OERL OC OERLIKON CORPORATION AG
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
NOEJ NORMA GROUP SE
NEX NEXANS SA
COR CORTICEIRA AMORIM SGPS SA
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BCHN BURCKHARDT COMPRESSION HOLDING AG
B7E BLUE CAP
COFA COFACE SA
ATRY ATRYS HEALTH
SFQ SAF-HOLLAND SE
ADTN ADTRAN HOLDINGS INC
- Christophe Chaput
- Christophe Chaput
WINFARM : Modalités de mise à disposition du Rapport Financier Semestr...
WINFARM : Modalités de mise à disposition du Rapport Financier Semestriel 2025. COMMUNIQUE DE PRESSE Loudéac, le 28 octobre 2025 MODALITES DE MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2025 WINFARM (code ISIN : FR0014000P11 - mnémonique : ALWF), n°1 français de la vente à distance pour le monde agricole, annonce que son rapport financier semestriel 2025 a été déposé auprès de l’Autorité des Marchés Financiers (AMF), le 28 octobre 2025. Ce document est disponible sur le site de la Société à l’adresse -group.com et sur le site de l’AMF (-france.org). Il est également tenu à disp...
Pharming Group announces presentations at 2025 ACAAI Annual Scientific...
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12 abstracts have been accepted for presentation at the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting taking place in Orlando, Florida on November 6-10. Five posters will present positive new clinical, economic, and comparative data for RUCONEST® (recombinant C1 esterase inhibi...
Pharming Group provides update on previously announced G&A expense red...
Pharming Group provides update on previously announced G&A expense reduction plan Leiden, the Netherlands, October 6, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the implementation of an organizational restructuring to accelerate the Company’s growth. The restructuring is aligned with our previously announced plan to reduce general and administrative (G&A) expenses to optimize capital allocation across the organization. The restructuring includes a redesign of Pharming’s organizational structure and a 20% net reduction in non-com...
Very sharp increase in EBITDA, cash generation and debt reduction in H...
Very sharp increase in EBITDA, cash generation and debt reduction in H1 2025 PRESS RELEASE Loudéac, 2 October 2025 Very sharp increase in EBITDA, cash generation and debt reduction in H1 2025 Outlook for 2025: continued growth, improvement in operating profitability and debt reduction WINFARM (ISIN: FR0014000P11 - ticker: ALWF), the leading French player in distance-selling of products and solutions for the agricultural and livestock industry, is today publishing its consolidated results for the first half of 2025. At its meeting on 1 October 2025, the Board of Directors approv...
Très forte hausse de l’EBITDA, génération de cash et baisse de l’endet...
Très forte hausse de l’EBITDA, génération de cash et baisse de l’endettement au 1er semestre 2025 COMMUNIQUE DE PRESSE Loudéac, 2 octobre 2025 Très forte hausse de l’EBITDA, génération de cash et baisse de l’endettement au 1er semestre 2025 Perspectives 2025 : poursuite de la croissance, amélioration de la rentabilité opérationnelle et désendettement WINFARM (code ISIN : FR0014000P11 - mnémonique : ALWF), n°1 français de la vente à distance pour le monde agricole, publie aujourd’hui ses résultats consolidés du 1er semestre 2025. Le Conseil d’administration du 1er octobre 2025 a...
Pharming Group announces U.S. FDA acceptance and Priority Review of su...
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiencyDecision based on positive data from multinational Phase III study in children aged 4 to 11 years with APDSPDUFA target action date of January 31, 2026 Leiden, the Netherlands, October 1, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: ...
- Maxime Kogge
PEO BANK POLSKA KASA OPIEKI SA
SDG SYNERGIE SA
INF INFOTEL SA
BEN BENETEAU SA
PKO PKO BANK POLSKI S.A.
FAGR FAGRON SA
VRAP VRANKEN-POMMERY MONOPOLE SA
GBT GUERBET SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ERA ERAMET SA
QDT QUADIENT SA
SPL SANTANDER BANK POLSKA SA
MIL BANK MILLENNIUM SA
TWEKA TKH GROUP N.V. CERT
ALR ALIOR BANK SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
VK VALLOUREC SA
ALVGO VOGO SA
ARVEN ARVERNE GROUP SA
MFEA MEDIASET NV
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
AAL ANGLO AMERICAN PLC
- Maxime Kogge
INF INFOTEL SA
BEN BENETEAU SA
FAGR FAGRON SA
VRAP VRANKEN-POMMERY MONOPOLE SA
GBT GUERBET SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ERA ERAMET SA
QDT QUADIENT SA
TWEKA TKH GROUP N.V. CERT
RIO RIO TINTO PLC
BHP BHP GROUP LTD
VK VALLOUREC SA
ALVGO VOGO SA
ARVEN ARVERNE GROUP SA
MFEA MEDIASET NV
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
AAL ANGLO AMERICAN PLC
- Christophe Chaput
- Christophe Chaput
Pharming Group promoted to the Euronext AMX® index
Pharming Group promoted to the Euronext AMX® index Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small Cap) to the AMX® (MidCap) index, effective from September 22, 2025. Euronext Amsterdam announced the results of its review of the AMX index, which comprises 25 companies based on free-float market capitalization and liquidity. This marks Pharming’s return to the AMX index, reflecting the Company’s strong growth momentum. Fabrice Chouraqui, Ch...
Revenue growth of 6.4% in H1 2025
Revenue growth of 6.4% in H1 2025 PRESS RELEASE Loudéac, 3 September 2025 Revenue growth of 6.4% in H1 2025 Growth in all of the Group’s activities Improvement in EBITDA expected over full-year 2025 WINFARM (ISIN: FR0014000P11 - ticker: ALWF), the leading French player in consulting, services and distance-selling of products and solutions for the agricultural and livestock industry, is today publishing its revenue figures for Q2 2025 and H1 2025. In millions of euros, unaudited Q2 2024Q2 2025Change H1 2024H1 2025ChangeFarming Supplies 32.833.7+2.7% 62.765.1+3.9%Farming Production 2.93...
Croissance de +6,4% du chiffre d’affaires au 1er semestre 2025
Croissance de +6,4% du chiffre d’affaires au 1er semestre 2025 COMMUNIQUE DE PRESSE Loudéac, le 3 septembre 2025 Croissance de +6,4% du chiffre d’affaires au 1er semestre 2025 Toutes les activités du Groupe sont en progression Amélioration de l’EBITDA anticipée sur l’exercice 2025 WINFARM (ISIN : FR0014000P11 – mnémonique : ALWF), 1er groupe français proposant un ensemble de prestations de conseil, de service, et de vente à distance de produits et de solutions au monde agricole et à l’élevage, annonce ce jour la publication du chiffre d’affaires du 2ème trimestre 2025 et en cumul sur ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.